Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Docetaxel plus ADT in metastatic prostate cancer
NCT03061643Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Feb 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate adenocarcinoma, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT03061643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061643.